Rapid detection of cytomegalovirus infection in immunocompromised patients

Area of Science:

• Virology
• Immunology
• Clinical Diagnostics

Background:

• Human cytomegalovirus (CMV) infection poses a significant risk to immunocompromised patients.
• Early and rapid diagnosis is crucial for timely therapeutic intervention and improved patient outcomes.
• Evaluating the efficacy of various diagnostic methods is essential for clinical practice.

Purpose of the Study:

• To assess the utility of routinely used diagnostic methods for early and rapid diagnosis of CMV infection.
• To compare the performance of conventional culture, shell vial assay, pp65 antigen detection, and polymerase chain reaction (PCR).
• To identify the most effective method for diagnosing CMV in immunocompromised individuals.

Main Methods:

• Analysis of clinical samples from immunocompromised patients over an 18-month period.
• Application of conventional viral culture, shell vial method, pp65 antigen detection in peripheral leukocytes, and PCR.
• Comparison of turnaround times and diagnostic sensitivity of each method.

Main Results:

• Detection of pp65 antigen in peripheral leukocytes demonstrated the highest utility for rapid and early diagnosis.
• Shell vial method and PCR provided valuable supportive data for diagnosis.
• Conventional culture results were often delayed, becoming available only after therapy initiation.
• Serological tests offered limited utility in guiding treatment decisions.

Conclusions:

• pp65 antigen detection is the preferred method for rapid CMV diagnosis in immunocompromised patients.
• Rapid diagnostic techniques like shell vial and PCR are beneficial adjuncts.
• Conventional culture is inadequate for timely diagnosis in this patient group.
• Careful selection of diagnostic methods is critical for effective CMV management.